These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6292979)

  • 1. Lack of effect of raphe lesions on serotonin S2 receptor changes induced by amitriptyline and desmethylimipramine.
    Dumbrille-Ross A; Tang SW; Coscina DV
    Psychiatry Res; 1982 Oct; 7(2):145-51. PubMed ID: 6292979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors.
    Tang SW; Seeman P; Kwan S
    Psychiatry Res; 1981 Apr; 4(2):129-38. PubMed ID: 6939004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
    List SJ; Seeman P
    Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid down-regulation of serotonin2 receptor binding during combined administration of tricyclic antidepressant drugs and alpha 2 antagonists.
    Crews FT; Scott JA; Shorstein NH
    Neuropharmacology; 1983 Oct; 22(10):1203-9. PubMed ID: 6139768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
    Akiyama K; Sato M; Kashihara K; Otsuki S
    Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulations of synaptic serotonin: discrepancy of effects on serotonin S1 and S2 sites.
    Dumbrille-Ross A; Tang SW
    Life Sci; 1983 Jun; 32(23):2677-84. PubMed ID: 6602261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
    Blurton PA; Wood MD
    J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
    Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
    Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple serotonin receptors: regional distribution and effect of Raphe lesions.
    Blackshear MA; Steranka LR; Sanders-Bush E
    Eur J Pharmacol; 1981 Dec; 76(4):325-34. PubMed ID: 7327207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic control of dopamine and serotonin receptors in brain regions of inbred mice.
    Boehme RE; Ciaranello RD
    Brain Res; 1983 Apr; 266(1):51-65. PubMed ID: 6850346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic and serotonergic input necessary for imipramine-induced changes in beta but not S2 receptor densities.
    Dumbrille-Ross A; Tang SW
    Psychiatry Res; 1983 Jul; 9(3):207-15. PubMed ID: 6312480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation of 3H-spiperone labeled 5-HT receptors by subchronic treatment with the ganglioside GM1 in the rat.
    Agnati LF; Benfenati F; Battistini N; Cavicchioli L; Fuxe K; Toffano G
    Acta Physiol Scand; 1983 Feb; 117(2):311-4. PubMed ID: 6869038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.